Lysosomes function as active aging controllers through two newly identified mechanisms: the lysosomal surveillance response (LySR) and transgenerational lysosomal signaling, both extending organismal longevity. The transcription factor EB (TFEB) serves as the central hub linking lysosomal activity to cellular senescence and tissue homeostasis, integrating stress and metabolic signals to modulate aging programs. This paradigm shift moves beyond viewing lysosomes as passive waste disposal units to recognizing them as dynamic signaling hubs that govern longevity. The implications are profound for aging research, as targeting lysosomal pathways could offer precise therapeutic interventions for extending healthspan. Unlike broad anti-aging approaches that often produce mixed results, lysosomal modulation provides specific molecular targets through TFEB activation and surveillance response enhancement. This represents a potentially transformative approach to aging intervention, moving from treating age-related diseases after they develop to preventing cellular aging at its source. The transgenerational component suggests these benefits could extend beyond individual lifespans, though translation to human applications will require extensive validation of these predominantly preclinical findings.